Gastrointestinal cancer: Novel promising first-line combination
Sign Up to like & getrecommendations! Published in 2018 at "Nature Reviews Clinical Oncology"
DOI: 10.1038/nrclinonc.2018.7
Abstract: Changes in serum prostate-specific antigen (PSA) levels, commonly used to evaluate the response of patients with metastatic castration-resistant prostate cancer to treatment, correlate poorly with overall survival. Circulating tumour cell (CTC) counts were explored as… read more here.
Keywords: novel promising; first line; gastrointestinal cancer; cancer novel ... See more keywords